
Vials
Melanotan 2 (MT2) 10mg
A cyclic α-MSH analogue studied for melanogenesis, photoprotection and broad melanocortin receptor research.
Melanotan 2 (MT2) is a cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH), structurally modified to resist enzymatic degradation and provide a much longer duration of action than the native hormone. It is studied for melanogenesis, pigmentation pathways, and broader melanocortin receptor research. This batch is verified at 99% purity.
Specifications
Research Benefits
- Melanogenesis stimulation — Activates MC1R receptors to promote melanin synthesis in melanocytes.
- Photoprotection research — Investigated for potential protective effects against UV-induced DNA damage.
- Broad melanocortin activity — Useful for researching MC1R, MC3R, MC4R, and MC5R receptor interactions.
- Appetite pathway overlap — MC4R activation is separately linked to satiety signalling in the research literature.
- Extended stability — Lyophilised format supports a long shelf life when stored correctly.
How It Works
Its broader affinity across MC1R, MC3R, MC4R, and MC5R (compared with more selective analogues) makes it a versatile tool for research into the melanocortin system as a whole, though this same breadth means effects beyond pigmentation may be observed in study models.
⚠ For Research Use Only
By purchasing, the buyer confirms this product is being acquired for legitimate research purposes and assumes full responsibility for its handling, storage, and use in compliance with all applicable local, national, and international laws.
More Vials

Vials
5-Amino-1MQ 50mg
A selective NNMT inhibitor studied for reducing fat-cell formation and preserving cellular NAD+ levels.
View
Vials
AOD-9604
A modified HGH fragment (176-191) studied for fat metabolism without growth-hormone-linked anabolic activity.
View
Vials
BPC-157 5mg
A gastric-derived pentadecapeptide extensively studied for tendon, gut and musculoskeletal tissue repair.
View